DOI: http://dx.doi.org/10.18203/2349-3933.ijam20195669

Islets of hypoglycaemia: a rare case of adult onset nesidioblastosis

Madhumathi R., Mohan C. N., Prabhu S.

Abstract


A case of diffuse nesidioblastosis in an adult patient is reported in this study. A 24-year-old female with no known comorbidities presented with multiple episodes of documented recurrent hypoglycaemia and Hypoglycaemia induced seizures both in fasting and postprandial state. Her blood investigations revealed low plasma glucose levels, high insulin and C-peptide levels with positive 72-hour fast test. Her transabdominal USG and CECT abdomen did not reveal any abnormality, 68Ga DOTANOC PET CT done showed ill-defined diffuse somatostatin receptor expression in the pancreatic head and tail suggestive of nesidioblastosis. As patient was not willing for surgical treatment, hence started on medical treatment with oral nifedipine. Nesidioblastosis is very rare in adults. It is an important differential diagnosis in adults with hyperinsulinemic hypoglycemia although the incidence is very rare in adults. PET SCAN was used to non-invasively diagnose nesidioblastosis in this case. Surgery being the preferred choice of treatment in nesidioblastosis, there is limited data on medical line of management in nesidioblastosis.


Keywords


68Ga DOTANOC, Hypoglycemia, Nesidioblastosis

Full Text:

PDF

References


Laidlaw GF. Nesidioblastoma, the islet tumor of the pancreas. Am J Pathol. 1938;14:125-134.

Davis SN, Lamos EM, Younk LM. Hypoglycemia and hypoglycemic syndromes. In: Jameson JL, De Groot LJ. Endocrinology: adult and paediatrics. 7th ed. Philadelphia: Elsevier saunders; 2016:816-838.

Albers N, Löhr M, Bogner U, Loy V, Klöppel G. Nesidioblastosis of the pancreas in an adult with persistent hyperinsulinemic hypoglycemia. Am J Clini Pathol. 1989 Mar 1;91(3):336-40.

Sanli Y, Garg I, Kandathil A, Kendi T, Zanetti MJ, Kuyumcu S, et al. Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET/CT. Am J Roentgenol. 2018 Aug;211(2):267-77.

Wild D, Bomanji JB, Benkert P, Maecke H, Ell PJ, Reubi JC, et al. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors. J Nuclear Med. 2013 Mar 1;54(3):364-72.

de Lonlay-Debeney P, Travert F, Fournet JC, Sempoux C, Vici CD, Brunelle F, et al. Clinical features of 52 neonates with hyperinsulinism. N Engl J Med. 1999;340(15):1169-75.

McLaughlin T, Peck M, Holst J, Deacon C. Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clini Endocrinol Metab. 2010 Apr 1;95(4):1851-5.

Hope TA, Bergsland EK, Bozkurt MF, Graham M, Heaney AP, Herrmann K, et al. Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors. J Nuclear Med. 2018 Jan 1;59(1):66-74.

Sundin A, Garske U, Örlefors H. Nuclear imaging of neuroendocrine tumours. Best Prac Res Clini Endocrinol Metab. 2007 Mar 1;21(1):69-85.

Ribeiro MJ, De Lonlay P, Delzescaux T, Boddaert N, Jaubert F, Bourgeois S, et al. Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA. J Nuclear Med. 2005 Apr 1;46(4):560-6.

Hardy OT, Hernandez-Pampaloni M, Saffer JR, Suchi M, Ruchelli E, Zhuang H, et al. Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan. J Pediatr. 2007 Feb 1;150(2):140-5.

Mojtahedi A, Thamake S, Tworowska I, Ranganathan D, Delpassand ES. The value of 68Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature. Am J Nuclear Med Molec Imaging. 2014;4(5):426.

Witteles RM, Straus FH, Sugg SL, Koka MR, Costa EA, Kaplan EL. Adult-onset nesidioblastosis causing hypoglycemia: an important clinical entity and continuing treatment dilemma. Archi Surg. 2001 Jun 1;136(6):656-63.

Arao T, Okada Y, Hirose A, Tanaka Y. A rare case of adult-onset nesidioblastosis treated successfully with diazoxide. Endo J. 2006;53(1):95-100.

Ritz P, Vaurs C, Bertrand M, Anduze Y, Guillaume E, Hanaire H. Usefulness of acarbose and dietary modifications to limit glycemic variability following Roux-en-Y gastric bypass as assessed by continuous glucose monitoring. Diabetes Tech Thera. 2012 Aug 1;14(8):736-40.

Mozell EJ, Woltering EA, O'Dorisio TM, Phillipson BE, Fletcher J, Fletcher WS, et al. Adult onset nesidioblastosis: response of glucose, insulin, and secondary peptides to therapy with sandostatin. Am J Gastroenterol. 1990 Feb 1;85(2).

Shanbag P, Pathak A, Vaidya M, Shahid SK. Persistent hyperinsulinemic hypoglycemia of infancy successful therapy with nifedipine. Ind J Pediatr. 2002;69:271-2.

Bas F, Darendeliler F, Demirkol D, Bundak R, Saka N, Gunöz H. Successful therapy with calcium channel blocker (nifedipine) in persistent neonatal hyperinsulinemic hypoglycemia of infancy. J Pediatr Endocrinol Metab. 1999;12:873-8.

Salehi M, Vella A, McLaughlin T, Patti ME. Hypoglycemia after gastric bypass surgery: current concepts and controversies. J Clini Endocrinol Metab. 2018 May 4;103(8):2815-26.